Medifast (NYSE:MED – Get Free Report) and TDH (NASDAQ:PETZ – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, profitability and earnings.
Earnings and Valuation
This table compares Medifast and TDH”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medifast | $385.79 million | 0.31 | -$18.67 million | ($1.83) | -5.84 |
| TDH | $1.25 million | 9.08 | $1.80 million | N/A | N/A |
Insider & Institutional Ownership
95.5% of Medifast shares are held by institutional investors. Comparatively, 0.0% of TDH shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 10.8% of TDH shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares Medifast and TDH’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medifast | -5.78% | -4.80% | -3.83% |
| TDH | N/A | N/A | N/A |
Volatility and Risk
Medifast has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, TDH has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Medifast and TDH, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medifast | 1 | 1 | 0 | 0 | 1.50 |
| TDH | 1 | 0 | 0 | 0 | 1.00 |
Medifast currently has a consensus target price of $12.00, suggesting a potential upside of 12.28%. Given Medifast’s stronger consensus rating and higher possible upside, equities analysts plainly believe Medifast is more favorable than TDH.
Summary
TDH beats Medifast on 7 of the 11 factors compared between the two stocks.
About Medifast
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
About TDH
TDH Holdings, Inc. engages in the restaurant operation business in the United States. Its restaurants provide dining area, bar, catering services, and space for banquets. The Company also runs restaurant business in the United States. TDH Holdings, Inc. was founded in 2002 and is based in Qingdao, the People's Republic of China.
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.
